ARCHIVES

Revlimid Also Demonstrates Response in Mantle Cell

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

May 22, 1998

Conversations With The Cancer Letter: Youle: ACS Stance on Tobacco Sales Is Clear

April 18, 2014

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

March 14, 2008

New Publications

January 20, 1989

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992